Literature DB >> 28453621

Prevalence of malignant arrhythmia and sudden cardiac death in takotsubo syndrome and its management.

Ibrahim El-Battrawy1,2, Siegfried Lang1,2, Uzair Ansari1, Erol Tülümen1, Katja Schramm1, Christian Fastner1, Xiaobo Zhou1,2, Ursula Hoffmann1, Martin Borggrefe1,2, Ibrahim Akin1,2.   

Abstract

Aims: Recent studies have highlighted that takotsubo syndrome (TTS) is associated with a poor clinical outcome. Our study was conducted to determine the short- and long-term prevalence, recurrence rate and impact of life-threatening arrhythmias (LTA) on the clinical outcome of TTS. Methods and results: Our institutional database constituted a collective of 114 patients diagnosed with TTS between 2003 and 2015. The patient groups, divided according to the presence (n = 13, 11.4%) or absence (n = 101, 88.6%) of LTAs, were followed-up over a period of 3 years so as to determine the clinical outcome. Our analyses suggest that patients comprising the LTA group suffered significantly more often from an acute cardiovascular event including cases of a newly diagnosed atrial fibrillation (38.4% vs. 2.9%), cardiogenic shock with use of inotropic agents (53.8% vs. 14.8%) and cardiopulmonary resuscitation (61.5% vs. 1%). The short-term recurrence rate of a LTA episode was 15.3%, while the long-term recurrence rate of any LTA was around 5%. Whereas, in-hospital mortality was significantly higher in TTS associated with LTAs, the overall survival rate over 3 years was similar. A multivariate Cox regression analysis suggested atrial fibrillation, EF ≤ 35%, cardiogenic shock, and glomerular filtration rate <60 mL/min. as independent predictors of adverse outcome.
Conclusion: The short- as well as the long-term prevalence and recurrence of LTAs in TTS patients is high. The long-term mortality rates were similar to the TTS patients presenting without any LTAs. LTAs in TTS could be triggered by a concomitant atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28453621     DOI: 10.1093/europace/eux073

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  25 in total

Review 1.  Prevalence, management, and outcome of adverse rhythm disorders in takotsubo syndrome: insights from the international multicenter GEIST registry.

Authors:  Ibrahim El-Battrawy; Francesco Santoro; Thomas Stiermaier; Christian Möller; Francesca Guastafierro; Giuseppina Novo; Salvatore Novo; Andrea Santangelo; Enrica Mariano; Francesco Romeo; Fabiana Romeo; Holger Thiele; Federico Guerra; Alessandro Capucci; Irene Giannini; Pasquale Caldarola; Natale Daniele Brunetti; Ingo Eitel; Ibrahim Akin
Journal:  Heart Fail Rev       Date:  2020-05       Impact factor: 4.214

Review 2.  Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases.

Authors:  Sophie I Mavrogeni; Petros P Sfikakis; Theodoros Dimitroulas; Loukia Koutsogeorgopoulou; George Markousis-Mavrogenis; George Poulos; Genovefa Kolovou; George Theodorakis; George D Kitas
Journal:  Rheumatol Int       Date:  2018-07-24       Impact factor: 2.631

3.  The presence of atrial fibrillation in Takotsubo cardiomyopathy is predictive of mortality: Systematic review and meta-analysis.

Authors:  Narut Prasitlumkum; Veraprapas Kittipibul; Nath Limpruttidham; Pattara Rattanawong; Pakawat Chongsathidkiet; Thosaporn Boondarikpornpant
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-06-25       Impact factor: 1.468

4.  The Great Myocardial Mimic - Takotsubo Syndrome.

Authors:  Aura Vijiiac; Vlad Ploscaru; Radu-Gabriel Vatasescu
Journal:  Maedica (Bucur)       Date:  2020-03

5.  The Use of Beta Blockers in Takotsubo Syndrome as Compared to Acute Coronary Syndrome.

Authors:  Marvin Kummer; Ibrahim El-Battrawy; Thorsten Gietzen; Uzair Ansari; Michael Behnes; Siegfried Lang; Xiaobo Zhou; Martin Borggrefe; Ibrahim Akin
Journal:  Front Pharmacol       Date:  2020-05-14       Impact factor: 5.810

6.  Takotsubo syndrome with severe bradycardia initiated by seizure: Is the implantation of a permanent pacemaker necessary?

Authors:  Yoichi Imori; Yu-Ki Iwasaki; Hitoshi Takano; Wataru Shimizu
Journal:  BMJ Case Rep       Date:  2018-10-12

7.  Coronary Spasm and Polymorphic Ventricular Tachycardia One Year After Takotsubo.

Authors:  Noah N Williford; Alexander Mazur; Troy Rhodes; Elaine Demetroulis; Milena A Gebska
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-05-05

8.  Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy.

Authors:  Uzair Ansari; Ibrahim El-Battrawy; Christian Fastner; Michael Behnes; Katherine Sattler; Aydin Huseynov; Stefan Baumann; Erol Tülümen; Martin Borggrefe; Ibrahim Akin
Journal:  BMC Cardiovasc Disord       Date:  2018-03-20       Impact factor: 2.298

9.  Serious takotsubo cardiomyopathy: an autopsy case presenting severe irreversible myocardial damage after frequent episodes of recurrence.

Authors:  Kenichi Mizutani; Akihiro Shioya; Yasuyo Hirose; Ryuhei Saito; Sohsuke Yamada
Journal:  Diagn Pathol       Date:  2020-07-21       Impact factor: 2.644

Review 10.  Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connection.

Authors:  Nikolaos Kosmas; Antonis S Manolis; Nikolaos Dagres; Efstathios K Iliodromitis
Journal:  Europace       Date:  2020-09-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.